Investor Relations

914-345-7741
invest@regeneron.com

Questions for the Investor Relations Department can be submitted through the form below. Fields marked with an * are required.

 
 
 
 
 
 
This helps Regeneron Pharmaceuticals, Inc. prevent automated submissions.
 
Print Print page     Email Email page

Stock Information

NASDAQ:REGN
$24.69   - 0.81
Mar 12, 2010
4:00 PM ET
Quotes delay at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

Featured Report